Intelligent Bio Solutions Inc

Intelligent Bio Solutions expands clinical studies to secure FDA 510(k) approval, aiming to deliver real‑time diagnostics that improve patient outcomes and capture a multi‑billion U.S. market.

Intelligent Bio Solutions raises $10 M in a private placement, bolstering capital to speed non‑invasive diagnostic development and expand U.S. market reach.

Intelligent Bio Solutions Inc. has demonstrated steady growth and resilience in the volatile healthcare sector, with a stable stock price and promising financial metrics, positioning it for future success.